Portfolio Companies

Remiges Seed Companies

05/20/2019
We Remiges Biopharma Fund recognize we have a significant mission to create de novo companies based on intellectual properties from Japanese academic institutions. We, by ourselves or in collaboration with other investors, we have built 5 new life science companies in the US and Japan based on the intellectual properties from Japanese academic institutions to develop revolutionary therapeutics to satisfy unmet medical needs.